Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-11T03:59:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-03-03T23:03:42.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-02-17T19:05:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:02:08.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T11:19:27.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-01-27T05:11:40.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.